Biopsy guidance system gets FDA nod
This article was originally published in Clinica
Executive Summary
The US FDA has granted 510(k) clearance for GammaLoc, a lesion localisation system developed by Dilon Diagnostics for molecular imaging biopsy guidance. The system is designed to help doctors locate breast lesions and enable gamma-guided biopsies. The portable device compliments Dilon’s lead product, the Dilon 6800 Gamma Camera, the Newport News, Virginia firm said.
You may also be interested in...
Normality Reasserts Itself For Biotech IPOs
The highs of the COVID-19 era, and the lows that supplanted it, are beginning to fade.
MRM Health Pulls A Pouchitis Hit Out Of The Bag
The mid-stage success is encouraging, but taking on Takeda won’t be easy.
Novartis Draws Out Its APPLAUSE
Another data drop from Fabhalta’s IgAN trial looks encouraging, despite a missing abstract.